{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:03:58Z","timestamp":1789427038181,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Is there a difference in the breast cancer risk among women who underwent ART treatments compared to those who underwent medically assisted reproduction (MAR) infertility treatments or women of reproductive age in the general population?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The risk of breast cancer among women treated by ART was similar to the risk among women treated by MAR and women who did not undergo fertility treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Studies investigating breast cancer risk in women who have undergone fertility treatments have provided conflicting results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>A retrospective, population-based cohort study included women who underwent ART or MAR treatments and women who did not undergo fertility treatments from 1994 to 2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Women who underwent ART were matched one to one with women who underwent MAR treatments and one to one with woman from the general population of reproductive age, by year of birth and year of first delivery or nulliparity status. MAR women were also matched to ART women by treatment initiation calendar year. All included women were members of Maccabi Healthcare Services. Data regarding demographics, fertility treatments, BRCA mutation and possible confounders were obtained from the computerized database of electronic health records. The incidence of breast cancer after fertility treatments was compared to the matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Of 8\u00a025\u00a0721 women of reproductive age, 32\u00a0366 women who underwent ART were matched with patients treated by MAR (n\u2009=\u200932\u00a0366) and 32\u00a0366 women of reproductive age. A total of 984 women (1.0%) were diagnosed with breast cancer (mean follow-up period, 9.1\u2009\u00b1\u20096.3\u2009years; interquartile range [IQR], 3.8\u201313.7\u2009years). The incidence rates of breast cancer per 10\u00a0000 person-years were 11.9 (95% CI, 10.7\u201313.3), 10.7 (95% CI, 9.6\u201311.9) and 10.7 (95% CI, 9.6\u201312.0) in the ART group, MAR group and general population, respectively. The crude risk for breast cancer was similar in the ART group compared with the general population (hazard ratio (HR)\u2009=\u20091.10, 95% CI, 0.94\u20131.28) and in the ART group compared with the MAR group (HR\u2009=\u20091.00, 95% CI, 0.86\u20131.16). Further adjustment for age, BMI, smoking, socioeconomic status and parity did not substantially impact the hazard rates for breast cancer (ART vs general population: HR\u2009=\u20091.10, 95% CI, 0.94\u20131.28; ART vs MAR: HR\u2009=\u20090.99, 95% CI, 0.85\u20131.16). Among women diagnosed with breast cancer, the prevalence of BRCA1\/2 mutations and tumour staging did not differ between the ART, MAR and general population groups. Among women who underwent ART, no correlation was found between breast cancer and the number of ART cycles or the use of recombinant medications or urine-derived medications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The mean age of women at the end of follow-up was only 42\u2009years thus the study was not powered to detect potential differences in the risk of postmenopausal breast cancer. In addition, we did not sub-classify the exposed patients by the reason for infertility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Breast cancer incidence following ART was comparable to that in the general population or following MAR. Women undergoing fertility treatments and their clinicians may be reassured about the safety of assisted reproduction technologies in terms of premenopausal breast cancer risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>No specific funding was used and there are no competing interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deab270","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:34:31Z","timestamp":1638311671000},"page":"577-585","source":"Crossref","is-referenced-by-count":9,"title":["Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-9683","authenticated-orcid":false,"given":"R","family":"Machtinger","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Fallach","sequence":"additional","affiliation":[{"name":"Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-8995","authenticated-orcid":false,"given":"G","family":"Chodick","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Schiff","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Orvieto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Mashiach","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"2022030206053425400_deab270-B1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00006205-198802000-00030","article-title":"Furazolidone is an alternative treatment for Giardia lamblia","volume":"13","author":"Brinton","year":"1988","journal-title":"Nurse Pract"},{"key":"2022030206053425400_deab270-B2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton","year":"2013","journal-title":"Fertil Steril"},{"key":"2022030206053425400_deab270-B3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(02)04950-6","article-title":"Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women\u2019s Contraceptive and Reproductive Experiences Study","volume":"79","author":"Burkman","year":"2003","journal-title":"Fertil Steril"},{"key":"2022030206053425400_deab270-B4","doi-asserted-by":"crossref","first-page":"e51446","DOI":"10.1371\/journal.pone.0051446","article-title":"Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis","volume":"7","author":"Cheraghi","year":"2012","journal-title":"PLoS One"},{"key":"2022030206053425400_deab270-B5","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(17)30636-0","article-title":"Health and health care in Israel: an introduction","volume":"389","author":"Clarfield","year":"2017","journal-title":"Lancet"},{"key":"2022030206053425400_deab270-B6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N Engl J Med"},{"key":"2022030206053425400_deab270-B7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","article-title":"Cancer incidence in a cohort of infertile women who underwent in vitro fertilization","volume":"77","author":"Dor","year":"2002","journal-title":"Fertil Steril"},{"key":"2022030206053425400_deab270-B8"},{"key":"2022030206053425400_deab270-B9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","article-title":"Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies","volume":"150","author":"Gennari","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2022030206053425400_deab270-B10","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1158\/1055-9965.EPI-19-0652","article-title":"A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs","volume":"28","author":"Guleria","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022030206053425400_deab270-B11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/EJE-11-0812","article-title":"Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation","volume":"166","author":"Hamajima","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2022030206053425400_deab270-B12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1258\/096914107780154503","article-title":"Breast cancer screening\u2013prevalence of disease in women who only respond after an invitation reminder","volume":"14","author":"Hofvind","year":"2007","journal-title":"J Med Screen"},{"key":"2022030206053425400_deab270-B13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1055-9965.EPI-07-0075","article-title":"Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study","volume":"16","author":"Jensen","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022030206053425400_deab270-B14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/humrep\/deq307","article-title":"Malignancies among women who gave birth after in vitro fertilization","volume":"26","author":"K\u00e4ll\u00e9n","year":"2011","journal-title":"Hum Reprod"},{"key":"2022030206053425400_deab270-B15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2022030206053425400_deab270-B16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"; Endogenous Hormones and Breast Cancer Collaborative Group. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies","volume":"14","author":"Key","year":"2013","journal-title":"Lancet Oncol"},{"key":"2022030206053425400_deab270-B17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1300\/J002v35n01_11","article-title":"The family in Israel: between tradition and modernity","volume":"35","author":"Lavee","year":"2003","journal-title":"Marriage Fam Rev"},{"key":"2022030206053425400_deab270-B18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"2022030206053425400_deab270-B19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.fertnstert.2015.04.006","article-title":"Adverse pregnancy outcomes after in vitro fertilization: effect of number of embryos transferred and plurality at conception","volume":"104","author":"Luke","year":"2015","journal-title":"Fertil Steril"},{"key":"2022030206053425400_deab270-B20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/07357909509094464","article-title":"Estrogen use and cancer incidence: a review","volume":"13","author":"Lupulescu","year":"1995","journal-title":"Cancer Invest"},{"key":"2022030206053425400_deab270-B21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2407-3-11","article-title":"Relation between the rate of tumour cell proliferation and latency time in radiation associated breast cancer","volume":"3","author":"Olsson","year":"2003","journal-title":"BMC Cancer"},{"key":"2022030206053425400_deab270-B22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-007-9800-2","article-title":"The possible association between IVF and breast cancer incidence","volume":"15","author":"Pappo","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"2022030206053425400_deab270-B23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fertnstert.2021.02.030","article-title":"Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers","volume":"116","author":"Perri","year":"2021","journal-title":"Fertil Steril"},{"key":"2022030206053425400_deab270-B24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ijc.29069","article-title":"Risk of breast cancer following fertility treatment\u2014a registry based cohort study of parous women in Norway","volume":"136","author":"Reigstad","year":"2015","journal-title":"Int J Cancer"},{"key":"2022030206053425400_deab270-B25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-16-0809","article-title":"Cancer risk in women treated with fertility drugs according to parity status\u2014a registry-based cohort study","volume":"26","author":"Reigstad","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022030206053425400_deab270-B26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1023\/A:1011084821700","article-title":"Childless in the land of imperative motherhood: stigma and coping among infertile Israeli women","volume":"43","author":"Remennick","year":"2000","journal-title":"Sex Roles"},{"key":"2022030206053425400_deab270-B27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"2022030206053425400_deab270-B28","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"8","author":"Rizzuto","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2022030206053425400_deab270-B29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41591-021-01337-2","article-title":"COVID-19 dynamics after a national immunization program in Israel","volume":"27","author":"Rossman","year":"2021","journal-title":"Nat Med"},{"key":"2022030206053425400_deab270-B30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humupd\/dmt034","article-title":"IVF and breast cancer: a systematic review and meta-analysis","volume":"20","author":"Sergentanis","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2022030206053425400_deab270-B31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/humupd\/dmh021","article-title":"Fertility preservation in female patients","volume":"10","author":"Sonmezer","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2022030206053425400_deab270-B32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.2016.9389","article-title":"Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer","volume":"316","author":"van den Belt-Dusebout","year":"2016","journal-title":"JAMA"},{"key":"2022030206053425400_deab270-B33","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/humrep\/16.12.2691","article-title":"Mortality in a cohort of IVF patients","volume":"16","author":"Venn","year":"2001","journal-title":"Hum Reprod"},{"key":"2022030206053425400_deab270-B34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in vitro fertilisation","volume":"354","author":"Venn","year":"1999","journal-title":"Lancet"},{"key":"2022030206053425400_deab270-B35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","article-title":"Breast and ovarian cancer incidence after infertility and in vitro fertilisation","volume":"346","author":"Venn","year":"1995","journal-title":"Lancet"},{"key":"2022030206053425400_deab270-B36","doi-asserted-by":"crossref","first-page":"k2644","DOI":"10.1136\/bmj.k2644","article-title":"Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation","volume":"362","author":"Williams","year":"2018","journal-title":"BMJ"},{"key":"2022030206053425400_deab270-B37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/des031","article-title":"Cancer morbidity in a cohort of 9175 Finnish women treated for infertility","volume":"27","author":"Yli-Kuha","year":"2012","journal-title":"Hum Reprod"},{"key":"2022030206053425400_deab270-B38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/ijc.25207","article-title":"Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms","volume":"127","author":"Yue","year":"2010","journal-title":"Int J Cancer"},{"key":"2022030206053425400_deab270-B39","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/dep343","article-title":"on behalf of ICMART and WHO. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology","volume":"24","author":"Zegers-Hochschild","year":"2009","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/3\/577\/42673859\/deab270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/3\/577\/42673859\/deab270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T06:08:43Z","timestamp":1646201323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/3\/577\/6453854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab270","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,12,6]]}}}